Organogenesis (ORGO) Earnings Date, Estimates & Call Transcripts

$2.28
-0.03 (-1.30%)
(As of 05/9/2024 ET)

Earnings Summary

Latest
Earnings Date
May. 9Confirmed
Consensus EPS
(May. 9)
-$0.03
Skip Charts & View Estimated and Actual Earnings Data

ORGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organogenesis Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.01) EPS

ORGO Earnings Date and Information

Organogenesis last announced its earnings results on May 9th, 2024. The reported $0.00 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.03. Organogenesis has generated $0.04 earnings per share over the last year ($0.04 diluted earnings per share) and currently has a price-to-earnings ratio of 57.0. Organogenesis has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024.

Organogenesis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Confirmed)
-($0.03)-----  
11/9/2023Q3 2023$0.01$0.02+$0.01$0.02$112.75 million$108.53 million
8/9/2023Q2 2023$0.02$0.04+$0.02$0.04$115.25 million$117.32 million
5/10/2023Q1 2023-($0.02)($0.02)($0.02)-$107.64 million
3/1/2023Q4 2022-$0.06+$0.06$0.06-$115.52 million
11/9/2022Q3 2022$0.06$0.04($0.02)$0.08$121.40 million$116.86 million
8/9/2022Q2 2022$0.08$0.09+$0.01$0.11$121.00 million$121.40 million
5/10/2022Q1 2022$0.05$0.01($0.04)$0.02$96.15 million$98.12 million    
3/1/2022Q4 2021$0.08$0.41+$0.33$0.43$124.35 million$128.56 million
11/9/2021Q3 2021$0.06$0.09+$0.03$0.09$112.10 million$113.75 million    
8/9/2021Q2 2021$0.06$0.15+$0.09$0.15$105.65 million$123.20 million    
5/10/2021Q1 2021($0.04)$0.07+$0.11$0.07$86.30 million$102.55 million  

Organogenesis Earnings - Frequently Asked Questions

When is Organogenesis's earnings date?

Organogenesis has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on ORGO's earnings history.

Did Organogenesis beat their earnings estimates last quarter?

In the previous quarter, Organogenesis (NASDAQ:ORGO) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.03. Learn more on analysts' earnings estimate vs. ORGO's actual earnings.

How can I listen to Organogenesis's earnings conference call?

The conference call for Organogenesis's latest earnings report can be listened to online. Listen to Conference Call

How much revenue does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded annual revenue of $433.14 million.

How much profit does Organogenesis generate each year?

Organogenesis (NASDAQ:ORGO) has a recorded net income of $4.95 million. ORGO has generated $0.04 earnings per share over the last four quarters.

What is Organogenesis's price-to-earnings ratio?

Organogenesis (NASDAQ:ORGO) has a trailing price-to-earnings ratio of 57.01.


More Earnings Resources from MarketBeat

This page (NASDAQ:ORGO) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners